Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab

BACKGROUND: Despite the good outcomes achieved with intravitreal angiogenic therapy, a subset of neovascular age-related macular degeneration (AMD) patients experience resistance to therapy after repeated injections. Switching drugs could offer benefit to this group of patients. PURPOSE: To determin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Retina Vitreous
Main Authors: Hamid, Mohamed A., Abdelfattah, Nizar S., Salamzadeh, Jamshid, Abdelaziz, Sahar T. A., Sabry, Ahmed M., Mourad, Khaled M., Shehab, Azza A., Kuppermann, Baruch D.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017745/
https://ncbi.nlm.nih.gov/pubmed/33795022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-021-00299-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados